Our INVESTMENT Philosophy
Biopharmaceutical companies have the potential to discover and to develop innovative medicines, which have a significant impact on patients to overcome serious and life-threatening diseases. The discovery and successful development of such breakthrough therapies leads to unusually strong and long-lasting value appreciation of a firm’s equity.
Due to the vast complexities involved in drug development, new therapies and their development progress are often misunderstood by investors and analysts, resulting in investment opportunities due to improper valuations.
Drug discovery and development however, is a very complex and dynamic process. A high level of technical, business and legal acumen is required to successfully navigate a company through the discovery, clinical development, regulatory approval, and commercialization of a novel therapy. As a consequence, a very small percentage of discovered drugs actually make it past approval and into commercialization.